← Back to Clinical Trials
Recruiting NCT07190183

NCT07190183 Washed Microbiota Transplantation for Food Intolerance

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07190183
Status Recruiting
Phase
Sponsor The Second Hospital of Nanjing Medical University
Condition Food Intolerance
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-01-01
Primary Completion 2035-02-10

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
washed microbiota transplantation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-01-01 with a primary completion date of 2035-02-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Food intolerance (FI) is an adverse reaction to food caused by non-immune mechanisms, mainly related to digestive enzyme deficiencies (e.g. lactase deficiency), metabolic abnormalities (e.g. impaired absorption of fructose) or toxicity of food components (e.g. histamine). Unlike immune-mediated food allergy, FI symptoms are usually delayed (hours to days after ingestion) and mild, but are difficult to diagnose and manage clinically due to the complexity and variety of mechanisms that affect approximately 20% of the world's population.

Eligibility Criteria

Inclusion Criteria: 1. Food intolerance occurs through laboratory examination of at least two main foods 2. Underwent washed microbiota transplantation. Exclusion Criteria: 1. Expected survival time \<3 months; 2. Women who are pregnant or breastfeeding; 3. Other patients deemed not suitable for enrollment by the investigator.

Contact & Investigator

Central Contact

Faming Zhang, PhD

✉ fzhang@njmu.edu.cn

📞 086-025-58509883

Principal Investigator

Faming Zhang, PhD

PRINCIPAL INVESTIGATOR

The Second Hospital of Nanjing Medical University

Frequently Asked Questions

Who can join the NCT07190183 clinical trial?

This trial is open to participants of all sexes, studying Food Intolerance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07190183 currently recruiting?

Yes, NCT07190183 is actively recruiting participants. Contact the research team at fzhang@njmu.edu.cn for enrollment information.

Where is the NCT07190183 trial being conducted?

This trial is being conducted at Nanjing, China.

Who is sponsoring the NCT07190183 clinical trial?

NCT07190183 is sponsored by The Second Hospital of Nanjing Medical University. The principal investigator is Faming Zhang, PhD at The Second Hospital of Nanjing Medical University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology